SHINE Teams with LifeSci

2017-12-11T10:40:17+00:00

December 11, 2017 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that it has joined forces with investor relations firm, LifeSci Advisors, LLC (“LifeSci”) to anchor its outreach to the broader investment community.  LifeSci is […]

SHINE Teams with LifeSci 2017-12-11T10:40:17+00:00

SHINE Expands Patent Portfolio

2017-09-28T15:21:53+00:00

U.S. Patent No. 9,734,926 relates to producing medical isotopes and expires December 23, 2032. This achievement demonstrates SHINE’s ongoing commitment to innovation and leadership in the medical isotope industry.

SHINE Expands Patent Portfolio 2017-09-28T15:21:53+00:00

SHINE Selects Baker Concrete Construction

2017-11-16T12:23:33+00:00

SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that it has chosen Baker Concrete Construction, Inc. (Baker) to be the prime contractor for the construction of its medical isotope production facility in Janesville, Wisconsin.  In conjunction, Brad Wucherpfennig, President of Baker, has joined the SHINE board of directors.

SHINE Selects Baker Concrete Construction 2017-11-16T12:23:33+00:00

SHINE Presents at 2017 Mo-99 Topical Meeting

2017-09-01T12:42:29+00:00

Katrina Pitas, VP, Business Development Katrina Pitas, VP, Business Development

September 1, 2017  – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited […]

SHINE Presents at 2017 Mo-99 Topical Meeting 2017-09-01T12:42:29+00:00

Miltenberger Promoted to Chief of Staff

2017-08-24T15:24:42+00:00

August 24, 2017  – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Steve Miltenberger has been promoted to Chief of Staff. The announcement comes as the company prepares to build its facility in Janesville, Wisconsin, […]

Miltenberger Promoted to Chief of Staff 2017-08-24T15:24:42+00:00

SHINE Breaks Ground on Building One

2017-08-04T15:21:58+00:00

August 4, 2017

Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a groundbreaking ceremony yesterday to celebrate the start of construction on Building One.

The first building to be built for the SHINE campus, Building One will be one […]

SHINE Breaks Ground on Building One 2017-08-04T15:21:58+00:00

Martyn Coombs to Advise SHINE

2017-09-21T13:29:04+00:00


March 27, 2017 – Janesville, WI –
SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Martyn Coombs will become a Strategic Adviser to SHINE, on a part-time basis.  The announcement comes as the company prepares to build its […]

Martyn Coombs to Advise SHINE 2017-09-21T13:29:04+00:00

Gregory OD Smith Joins SHINE BOD

2017-08-01T08:31:20+00:00

February 13th, 2017 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Gregory Smith will join its Board of Directors. The appointment comes as the company prepares to build its facility in Janesville, Wisconsin, after receiving its construction permit from the U.S. Nuclear Regulatory Commission last year. The SHINE facility will produce molybdenum-99 (moly‑99) and other medical isotopes.

Gregory OD Smith Joins SHINE BOD 2017-08-01T08:31:20+00:00

SHINE Awarded $20.9M DOE/NNSA Phase II

2017-08-01T08:35:37+00:00

December 12, 2016 - SHINE Medical Technologies announced today that it has been awarded $10 million from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of a $20.9 million cooperative agreement.

SHINE Awarded $20.9M DOE/NNSA Phase II 2017-08-01T08:35:37+00:00

SHINE to Present at Piper Jaffray Healthcare Conference

2017-09-18T13:58:17+00:00

November 17, 2016 - SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 28th Annual Piper Jaffray Healthcare Conference in New York.

SHINE to Present at Piper Jaffray Healthcare Conference 2017-09-18T13:58:17+00:00